BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2002712)

  • 1. [New methods accelerate the development of thrombolytic agents].
    Wiman B; Hamsten A
    Lakartidningen; 1991 Jan; 88(1-2):37, 40-1. PubMed ID: 2002712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in clinical fibrinolysis.
    Hessel LW; Kluft C
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and clinical characteristics of thrombolytic agents.
    Deitcher SR; Jaff MR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic agents--an overview.
    Gulba DC; Bode C; Runge MS; Huber K
    Ann Hematol; 1996; 73 Suppl 1():S9-27. PubMed ID: 8853112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinolytic factors in ischaemia.
    Pandolfi M; al-Rushood A
    Eye (Lond); 1991; 5 ( Pt 2)():159-69. PubMed ID: 2070877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin-specific thrombolytic agents.
    Collen D
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the fibrinolytic system in the newborn].
    Schlegel N; Hurtaud-Roux MF; Beaufils F
    Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis and the risk of venous and arterial thrombosis.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.